Analyst Expectations for ANI Pharmaceuticals's Future
Portfolio Pulse from Benzinga Insights
ANI Pharmaceuticals (NASDAQ:ANIP) has received six bullish ratings from analysts in the last quarter. The average 12-month price target for the company, according to these analysts, is $68.17, an increase of 17.03% from the previous average price target of $58.25.
September 13, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ANI Pharmaceuticals has received positive ratings from analysts, with an increased average price target. This could potentially lead to an increase in the stock price.
Analysts play a significant role in influencing stock prices. Their ratings and price targets can sway investor sentiment. In this case, ANI Pharmaceuticals has received six bullish ratings and an increased average price target, which could potentially lead to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100